Genomic Study Maps Shared Risk Factors for 14 Psychiatric Disorders
December 14, 2025
Background
The disorder known as protein-losing enteropathy (PLE) is characterized by an excessive loss of digestive system proteins. Lower blood protein levels are the consequence of this loss which usually passes through the intestinal mucosa. Due to protein shortage and fluid imbalance, PLE can cause a variety of symptoms and problems.
PLE may result from several underlying gastrointestinal disorders.
In individuals suffering from severe gastrointestinal diseases, it makes up as much as 60% of the total albumin pool. As atypical presentation of several disorders that disrupt the equilibrium between protein synthesis and loss the syndrome is not a single disease. The primary sources of normal protein loss in the gastrointestinal tract include secretions from the pancreas and biliary system which shed enterocytes.
Epidemiology
Due to differences in diagnostic standards the variety of underlying illnesses is linked to PLE the dearth of extensive epidemiological studies concentrating on PLE is difficult to pinpoint the precise prevalence.
While PLE can happen to anyone at any age with certain underlying disorders that are linked to specific age distribution.
Anatomy
Pathophysiology
The barrier function of the intestinal mucosa controls the flow of liquids and nutrients into the systemic circulation from the intestinal lumen. This barrier may alter in PLE for several reasons including inflammation, lymphatic blockage, and injury to the intestinal epithelial cells.
Increased permeability brought on by disruption of the intestinal barrier may permit proteins to seep into the intestinal lumen from the circulation either transcellular and paracellular channels may be the source of this leak.
Etiology
This illness known as intestinal lymphangiectasia is typified by the enlargement and malfunction of the gut wall lymphatic vessels considered as acquired or congenital. While acquired forms can arise from illnesses including lymphatic obstruction linked to elevated lymphatic pressure where congenital forms can be caused by genetic abnormalities impacting lymphatic development.
Individuals with genetic predisposition and gluten consumption can result in autoimmune illness celiac disease. Consuming gluten triggers the immunological reaction that weakens the villous atrophy and hinders the absorption of nutrients or proteins.
Genetics
Prognostic Factors
The prognosis is largely dependent on the underlying illness in contrast to congenital intestinal lymphangiectasia or systemic lupus erythematosus these illnesses may have various prognoses.
The degree to which protein has been lost into the intestinal lumen is a critical prognostic factor and if treatment is not received for severe and prolonged protein loss might deteriorate prognosis leading to high risk.
Clinical History
Age Group:
PLE usually occur in ages of infants and children due to congenital or acquired conditions such as congenital intestinal lymphangiectasia, protein intolerance, and cow milk protein allergy.
Physical Examination
Age group
Associated comorbidity
Protein loss and hypoalbuminemia can lead to fluid accumulation in the interstitial spaces and abdominal cavity. Edema and ascites are common complications of PLE leads to discomfort, respiratory compromise, and impaired mobility.
Malnutrition results in weight loss and micronutrient deficiencies overall nutritional deficits affecting health and quality of life.
Chronic protein loss and malabsorption in PLE can contribute to the development of anemia resulting from impaired absorption of iron in the intestines.
Associated activity
Acuity of presentation
PLE may present acutely with sudden onset symptoms especially if the underlying cause is related to an acute gastrointestinal infection.
PLE may also present sub acutely or acute with symptoms developing over days to weeks rather than suddenly. These presentations may involve a gradual onset of symptoms such as chronic diarrhea and unintended weight loss.
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Dietary Modifications plays a crucial role in managing PLE with high-protein diet and adequate caloric intake is recommended to help replenish lost proteins and support nutritional needs.
Supportive Therapy measures may be necessary to manage complications associated with PLE.
Medications corticosteroids and monoclonal antibodies help in controling the symptoms of the disease where endoscopy and entereoscopy used to evaluate the small intestine.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
use-of-non-pharmacological-approach-for-protein-losing-enteropathy
High-Protein Diet helps as a diet rich in high-quality protein sources can help replenish lost proteins and support overall nutritional needs.
Reduced Fat Intake associated with fat malabsorption such as intestinal lymphangiectasia and reducing dietary fat intake may be beneficial.
Balanced Nutrition ensuring a balanced diet that provides adequate calories, vitamins, and minerals to improve overall health and supporting the body healing processes.
Fluid Management is important, especially in cases of diarrhea or fluid losses due to edema or ascites.
Physical Activity can promote overall health, improve gastrointestinal motility and support weight management.
Use of Corticosteroids
Prednisone is an anti-inflammatory drug that exerts the effects of suppressing immune responses and reducing inflammation in the gastrointestinal tract.
Use of monoclonal antibody
Pozelimab works by targeting and inhibiting the activity of angiopoietin-like protein which plays a role in the regulation of lymphatic vessel permeability.
use-of-intervention-with-a-procedure-in-treating-protein-losing-enteropathy
Endoscopy may be performed to visualize the mucosa of the esophagus, stomach, small intestine, and colon.
Balloon Enteroscopy allows for direct visualization of the small intestine using an endoscope with an inflatable balloon at its tip.
Capsule Endoscopy involves swallowing a small and wireless camera capsule that captures images of the gastrointestinal tract as it passes through the digestive system.
use-of-phases-in-managing-protein-losing-enteropathy
Initial Evaluation and Diagnosis: Diagnose PLE using history, physical examination, examination of sample of the feces (serum albumin, alpha-1 antitrypsin), and radiologic investigations. Identifying the possible primary processes (for example, gastrointestinal disorders, cardiac issues, infection).
Acute Management: Stabilize the patient by treatment of life-threatening manifestations and complications like severe hypoalbuminaemia, oedema, and malnutrition. This may require intravenous albumin, use of diuretics, and replacement of electrolytes where necessary.
Specific Treatment: It is recommended to address the cause of PLE as a way of preventing it. For example:
Cardiac PLE: Treat heart failure with pharmacological therapies and in some cases use invasive procedures.
Inflammatory or Infectious PLE: Pretend use of right anti-inflammatory or antimicrobial regimens.
Gastrointestinal Disorders: Use diet changes and medicines (for example corticosteroids, immunosuppressive medications) in situations such as Crohn’s disease or celiac sickness.
Nutritional Support: Introduce low fat diet high in protein in order to replace protein loss and improve nutritional health. There is also a need for supplemental vitamins and minerals depending on one’s specialized needs.
Medication
Future Trends
The disorder known as protein-losing enteropathy (PLE) is characterized by an excessive loss of digestive system proteins. Lower blood protein levels are the consequence of this loss which usually passes through the intestinal mucosa. Due to protein shortage and fluid imbalance, PLE can cause a variety of symptoms and problems.
PLE may result from several underlying gastrointestinal disorders.
In individuals suffering from severe gastrointestinal diseases, it makes up as much as 60% of the total albumin pool. As atypical presentation of several disorders that disrupt the equilibrium between protein synthesis and loss the syndrome is not a single disease. The primary sources of normal protein loss in the gastrointestinal tract include secretions from the pancreas and biliary system which shed enterocytes.
Due to differences in diagnostic standards the variety of underlying illnesses is linked to PLE the dearth of extensive epidemiological studies concentrating on PLE is difficult to pinpoint the precise prevalence.
While PLE can happen to anyone at any age with certain underlying disorders that are linked to specific age distribution.
The barrier function of the intestinal mucosa controls the flow of liquids and nutrients into the systemic circulation from the intestinal lumen. This barrier may alter in PLE for several reasons including inflammation, lymphatic blockage, and injury to the intestinal epithelial cells.
Increased permeability brought on by disruption of the intestinal barrier may permit proteins to seep into the intestinal lumen from the circulation either transcellular and paracellular channels may be the source of this leak.
This illness known as intestinal lymphangiectasia is typified by the enlargement and malfunction of the gut wall lymphatic vessels considered as acquired or congenital. While acquired forms can arise from illnesses including lymphatic obstruction linked to elevated lymphatic pressure where congenital forms can be caused by genetic abnormalities impacting lymphatic development.
Individuals with genetic predisposition and gluten consumption can result in autoimmune illness celiac disease. Consuming gluten triggers the immunological reaction that weakens the villous atrophy and hinders the absorption of nutrients or proteins.
The prognosis is largely dependent on the underlying illness in contrast to congenital intestinal lymphangiectasia or systemic lupus erythematosus these illnesses may have various prognoses.
The degree to which protein has been lost into the intestinal lumen is a critical prognostic factor and if treatment is not received for severe and prolonged protein loss might deteriorate prognosis leading to high risk.
Age Group:
PLE usually occur in ages of infants and children due to congenital or acquired conditions such as congenital intestinal lymphangiectasia, protein intolerance, and cow milk protein allergy.
Protein loss and hypoalbuminemia can lead to fluid accumulation in the interstitial spaces and abdominal cavity. Edema and ascites are common complications of PLE leads to discomfort, respiratory compromise, and impaired mobility.
Malnutrition results in weight loss and micronutrient deficiencies overall nutritional deficits affecting health and quality of life.
Chronic protein loss and malabsorption in PLE can contribute to the development of anemia resulting from impaired absorption of iron in the intestines.
PLE may present acutely with sudden onset symptoms especially if the underlying cause is related to an acute gastrointestinal infection.
PLE may also present sub acutely or acute with symptoms developing over days to weeks rather than suddenly. These presentations may involve a gradual onset of symptoms such as chronic diarrhea and unintended weight loss.
Dietary Modifications plays a crucial role in managing PLE with high-protein diet and adequate caloric intake is recommended to help replenish lost proteins and support nutritional needs.
Supportive Therapy measures may be necessary to manage complications associated with PLE.
Medications corticosteroids and monoclonal antibodies help in controling the symptoms of the disease where endoscopy and entereoscopy used to evaluate the small intestine.
Gastroenterology
Physical Medicine and Rehabilitation
High-Protein Diet helps as a diet rich in high-quality protein sources can help replenish lost proteins and support overall nutritional needs.
Reduced Fat Intake associated with fat malabsorption such as intestinal lymphangiectasia and reducing dietary fat intake may be beneficial.
Balanced Nutrition ensuring a balanced diet that provides adequate calories, vitamins, and minerals to improve overall health and supporting the body healing processes.
Fluid Management is important, especially in cases of diarrhea or fluid losses due to edema or ascites.
Physical Activity can promote overall health, improve gastrointestinal motility and support weight management.
Gastroenterology
Prednisone is an anti-inflammatory drug that exerts the effects of suppressing immune responses and reducing inflammation in the gastrointestinal tract.
Gastroenterology
Pozelimab works by targeting and inhibiting the activity of angiopoietin-like protein which plays a role in the regulation of lymphatic vessel permeability.
Gastroenterology
Surgery, General
Endoscopy may be performed to visualize the mucosa of the esophagus, stomach, small intestine, and colon.
Balloon Enteroscopy allows for direct visualization of the small intestine using an endoscope with an inflatable balloon at its tip.
Capsule Endoscopy involves swallowing a small and wireless camera capsule that captures images of the gastrointestinal tract as it passes through the digestive system.
Gastroenterology
Initial Evaluation and Diagnosis: Diagnose PLE using history, physical examination, examination of sample of the feces (serum albumin, alpha-1 antitrypsin), and radiologic investigations. Identifying the possible primary processes (for example, gastrointestinal disorders, cardiac issues, infection).
Acute Management: Stabilize the patient by treatment of life-threatening manifestations and complications like severe hypoalbuminaemia, oedema, and malnutrition. This may require intravenous albumin, use of diuretics, and replacement of electrolytes where necessary.
Specific Treatment: It is recommended to address the cause of PLE as a way of preventing it. For example:
Cardiac PLE: Treat heart failure with pharmacological therapies and in some cases use invasive procedures.
Inflammatory or Infectious PLE: Pretend use of right anti-inflammatory or antimicrobial regimens.
Gastrointestinal Disorders: Use diet changes and medicines (for example corticosteroids, immunosuppressive medications) in situations such as Crohn’s disease or celiac sickness.
Nutritional Support: Introduce low fat diet high in protein in order to replace protein loss and improve nutritional health. There is also a need for supplemental vitamins and minerals depending on one’s specialized needs.
The disorder known as protein-losing enteropathy (PLE) is characterized by an excessive loss of digestive system proteins. Lower blood protein levels are the consequence of this loss which usually passes through the intestinal mucosa. Due to protein shortage and fluid imbalance, PLE can cause a variety of symptoms and problems.
PLE may result from several underlying gastrointestinal disorders.
In individuals suffering from severe gastrointestinal diseases, it makes up as much as 60% of the total albumin pool. As atypical presentation of several disorders that disrupt the equilibrium between protein synthesis and loss the syndrome is not a single disease. The primary sources of normal protein loss in the gastrointestinal tract include secretions from the pancreas and biliary system which shed enterocytes.
Due to differences in diagnostic standards the variety of underlying illnesses is linked to PLE the dearth of extensive epidemiological studies concentrating on PLE is difficult to pinpoint the precise prevalence.
While PLE can happen to anyone at any age with certain underlying disorders that are linked to specific age distribution.
The barrier function of the intestinal mucosa controls the flow of liquids and nutrients into the systemic circulation from the intestinal lumen. This barrier may alter in PLE for several reasons including inflammation, lymphatic blockage, and injury to the intestinal epithelial cells.
Increased permeability brought on by disruption of the intestinal barrier may permit proteins to seep into the intestinal lumen from the circulation either transcellular and paracellular channels may be the source of this leak.
This illness known as intestinal lymphangiectasia is typified by the enlargement and malfunction of the gut wall lymphatic vessels considered as acquired or congenital. While acquired forms can arise from illnesses including lymphatic obstruction linked to elevated lymphatic pressure where congenital forms can be caused by genetic abnormalities impacting lymphatic development.
Individuals with genetic predisposition and gluten consumption can result in autoimmune illness celiac disease. Consuming gluten triggers the immunological reaction that weakens the villous atrophy and hinders the absorption of nutrients or proteins.
The prognosis is largely dependent on the underlying illness in contrast to congenital intestinal lymphangiectasia or systemic lupus erythematosus these illnesses may have various prognoses.
The degree to which protein has been lost into the intestinal lumen is a critical prognostic factor and if treatment is not received for severe and prolonged protein loss might deteriorate prognosis leading to high risk.
Age Group:
PLE usually occur in ages of infants and children due to congenital or acquired conditions such as congenital intestinal lymphangiectasia, protein intolerance, and cow milk protein allergy.
Protein loss and hypoalbuminemia can lead to fluid accumulation in the interstitial spaces and abdominal cavity. Edema and ascites are common complications of PLE leads to discomfort, respiratory compromise, and impaired mobility.
Malnutrition results in weight loss and micronutrient deficiencies overall nutritional deficits affecting health and quality of life.
Chronic protein loss and malabsorption in PLE can contribute to the development of anemia resulting from impaired absorption of iron in the intestines.
PLE may present acutely with sudden onset symptoms especially if the underlying cause is related to an acute gastrointestinal infection.
PLE may also present sub acutely or acute with symptoms developing over days to weeks rather than suddenly. These presentations may involve a gradual onset of symptoms such as chronic diarrhea and unintended weight loss.
Dietary Modifications plays a crucial role in managing PLE with high-protein diet and adequate caloric intake is recommended to help replenish lost proteins and support nutritional needs.
Supportive Therapy measures may be necessary to manage complications associated with PLE.
Medications corticosteroids and monoclonal antibodies help in controling the symptoms of the disease where endoscopy and entereoscopy used to evaluate the small intestine.
Gastroenterology
Physical Medicine and Rehabilitation
High-Protein Diet helps as a diet rich in high-quality protein sources can help replenish lost proteins and support overall nutritional needs.
Reduced Fat Intake associated with fat malabsorption such as intestinal lymphangiectasia and reducing dietary fat intake may be beneficial.
Balanced Nutrition ensuring a balanced diet that provides adequate calories, vitamins, and minerals to improve overall health and supporting the body healing processes.
Fluid Management is important, especially in cases of diarrhea or fluid losses due to edema or ascites.
Physical Activity can promote overall health, improve gastrointestinal motility and support weight management.
Gastroenterology
Prednisone is an anti-inflammatory drug that exerts the effects of suppressing immune responses and reducing inflammation in the gastrointestinal tract.
Gastroenterology
Pozelimab works by targeting and inhibiting the activity of angiopoietin-like protein which plays a role in the regulation of lymphatic vessel permeability.
Gastroenterology
Surgery, General
Endoscopy may be performed to visualize the mucosa of the esophagus, stomach, small intestine, and colon.
Balloon Enteroscopy allows for direct visualization of the small intestine using an endoscope with an inflatable balloon at its tip.
Capsule Endoscopy involves swallowing a small and wireless camera capsule that captures images of the gastrointestinal tract as it passes through the digestive system.
Gastroenterology
Initial Evaluation and Diagnosis: Diagnose PLE using history, physical examination, examination of sample of the feces (serum albumin, alpha-1 antitrypsin), and radiologic investigations. Identifying the possible primary processes (for example, gastrointestinal disorders, cardiac issues, infection).
Acute Management: Stabilize the patient by treatment of life-threatening manifestations and complications like severe hypoalbuminaemia, oedema, and malnutrition. This may require intravenous albumin, use of diuretics, and replacement of electrolytes where necessary.
Specific Treatment: It is recommended to address the cause of PLE as a way of preventing it. For example:
Cardiac PLE: Treat heart failure with pharmacological therapies and in some cases use invasive procedures.
Inflammatory or Infectious PLE: Pretend use of right anti-inflammatory or antimicrobial regimens.
Gastrointestinal Disorders: Use diet changes and medicines (for example corticosteroids, immunosuppressive medications) in situations such as Crohn’s disease or celiac sickness.
Nutritional Support: Introduce low fat diet high in protein in order to replace protein loss and improve nutritional health. There is also a need for supplemental vitamins and minerals depending on one’s specialized needs.

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
